Paroxetine Hydrochloride 30mg Tablets

Paroxetine Hydrochloride 30mg tablet is an SSRI antidepressant for depression and selected anxiety-related disorders, including panic disorder, obsessive-compulsive disorder, social anxiety, generalised anxiety and post-traumatic stress disorder. Response develops with regular treatment over several weeks.
Take the immediate-release tablet at a consistent daily time, usually in the morning, with or without food. Avoid abrupt cessation; the taper should reflect treatment duration, dose and previous withdrawal symptoms.
Inhibition of the serotonin transporter increases serotonin availability at synapses involved in mood and anxiety regulation.
Nausea, sweating, sleep disturbance, dry mouth, constipation and sexual dysfunction may occur.
Tell your doctor about bipolar disorder, low sodium, glaucoma and other serotonergic medicines. Do not combine paroxetine with MAO inhibitors. It can reduce tamoxifen activation. New suicidal thoughts or major behavioural changes need urgent assessment.
Can reduce persistent depressive or anxiety symptoms and associated functional impairment over continued treatment.
Mood and anxiety responses usually develop over several weeks rather than after one tablet.
Yes. Paroxetine can cause discontinuation symptoms after interruption or rapid reduction.
Discontinuation symptoms do not by themselves mean craving-based addiction, but gradual tapering is still important.
Reduced desire, delayed orgasm or other sexual effects can occur and should be discussed.
Paroxetine can reduce tamoxifen activation; the cancer team should select an appropriate alternative if needed.
Seek urgent care for possible serotonin syndrome, especially after adding another serotonergic medicine.
Yes. Discuss reproductive risks and alternatives without abruptly stopping treatment.
No. Release characteristics and conversion schedules differ.
SSRI: selective serotonin reuptake inhibitor. Discontinuation symptoms: symptoms after rapid dose reduction. Hyponatraemia: an abnormally low blood-sodium concentration.; AR: Paroxetine Hydrochloride 30mg أقراص; FR: Paroxetine Hydrochloride 30mg comprimés; PT: Paroxetine Hydrochloride 30mg comprimidos; ES: Paroxetine Hydrochloride 30mg comprimidos; RU: Paroxetine Hydrochloride 30mg таблетки; ID: Paroxetine Hydrochloride 30mg tablet; VI: Paroxetine Hydrochloride 30mg viên nén; MS: Paroxetine Hydrochloride 30mg tablet; TL: Paroxetine Hydrochloride 30mg tableta; ZH-SG: Paroxetine Hydrochloride 30mg 片剂
International B2B Enquiry
Send a structured B2B enquiry for Paroxetine Hydrochloride 30mg Tablets under Mental Health. Global Medicines Export helps international buyers review product information, pack details, quantity requirements, destination-market needs, quotation support and export documentation coordination from India.
Product name, required strength or pack, expected quantity, destination country, buyer type and preferred manufacturer if any.
Availability, quotation support, documentation expectations and shipment-ready order communication can be reviewed before confirmation.
Commercial invoice, packing information, manufacturer details, batch details and supporting documents where applicable and available.
Product availability, quotation, and documentation support are coordinated for international B2B enquiries.
Paroxetine Hydrochloride 30mg Tablets